Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New House FDA Appropriations Chair Aderholt An Unknown

Executive Summary

Alabama Republican Robert Aderholt takes over as FDA appropriations subcommittee chair after running homeland security subcommittee; Mikulski to run Senate Appropriations Committee.

You may also be interested in...



Increased FDA China Inspections Backed By House Panel, While Purse Strings Pulled Still Tighter

Funds for the Reagan-Udall Foundation must come from the FDA commissioner’s office account, under successful amendment from Rep. DeLauro.

FDA’s IT Systems Painted With Bull’s-eye By Senate Funding Panel

The Senate Appropriations Committee April 26 approves a $3.9 billion spending plan for the agency in fiscal 2013, providing a $12.5 million boost in Treasury spending over President Obama’s proposed budget, with the extra funds slated for the food and animal drug programs.

Drug Shortage Legislation: Sen. Blumenthal Calls For More Extensive Effort

Democratic Senator has terse exchange with FDA at hearing and says Congress must do more than what is already in pending legislation. Blumenthal said he is willing to consider the Generic Pharmaceutical Association proposal calling for an independent third party to compile supplier data and predict coming shortages.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS055036

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel